BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 20, Issue 2
This Article
Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (11164)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.
Item 
Count 
PDF616
WORD243
HTML7300
Figures (1-4)250
Tables (1-3)238
 Sum=8647
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1209
Download1308
 Sum=2517
Jan 14, 2014 (publication date) through Nov 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: El-Salhy M, Gundersen D, Gilja OH, Hatlebakk JG, Hausken T. Is irritable bowel syndrome an organic disorder? World J Gastroenterol 2014; 20(2): 384-400 [PMID: 24574708 DOI: 10.3748/wjg.v20.i2.384]
URL: https://www.wjgnet.com/1007-9327/full/v20/i2/384.htm
Number Citing Articles
1
Magdy El-Salhy, Jan Gunnar Hatlebakk, Trygve Hausken. Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities. World Journal of Gastroenterology 2015; 21(32): 9577-9587 doi: 10.3748/wjg.v21.i32.9577
2
Emanuele Sinagra, Giancarlo Pompei, Giovanni Tomasello, Francesco Cappello, Gaetano Cristian Morreale, Georgios Amvrosiadis, Francesca Rossi, Attilio Ignazio Lo Monte, Aroldo Gabriele Rizzo, Dario Raimondo. Inflammation in irritable bowel syndrome: Myth or new treatment target?. World Journal of Gastroenterology 2016; 22(7): 2242-2255 doi: 10.3748/wjg.v22.i7.2242
3
R. Carmona-Sánchez, M.E. Icaza-Chávez, M.V. Bielsa-Fernández, O. Gómez-Escudero, F. Bosques-Padilla, E. Coss-Adame, F. Esquivel-Ayanegui, Á.R. Flores-Rendón, M.A. González-Martínez, F. Huerta-Iga, A. López-Colombo, T.H. Méndez-Gutiérrez, A. Noble-Lugo, J.R. Nogueira-de Rojas, R.H. Raña-Garibay, J.M. Remes-Troche, F. Roesch-Dietlen, M.J. Schmulson, J.C. Soto-Pérez, J.L. Tamayo, L.F. Uscanga, M.Á. Valdovinos, J. Valerio-Ureña, M.R. Zavala-Solares. Consenso mexicano sobre el síndrome de intestino irritable. Revista de Gastroenterología de México 2016; 81(3): 149 doi: 10.1016/j.rgmx.2016.01.004
4
Tai Zhang, Xiangxue Ma, Wende Tian, Jiaqi Zhang, Yuchen Wei, Beihua Zhang, Fengyun Wang, Xudong Tang. Global Research Trends in Irritable Bowel Syndrome: A Bibliometric and Visualized Study. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.922063
5
Magdy El-Salhy, Odd Helge Gilja. Abnormalities in ileal stem, neurogenin 3, and enteroendocrine cells in patients with irritable bowel syndrome. BMC Gastroenterology 2017; 17(1) doi: 10.1186/s12876-017-0643-4
6
Jinfeng Chen, Tingting Zhang, Yang Liu, Xueqian Dong, Jianjun Liu. Animal models with characteristics of irritable bowel syndrome with diarrhea: current applications and future perspectives. American Journal of Physiology-Gastrointestinal and Liver Physiology 2024; 327(3): G360 doi: 10.1152/ajpgi.00060.2024
7
György Bárdos. Irritable bowel syndrome (IBS): could we decide what is behind?. Biologia Futura 2024; 75(1): 61 doi: 10.1007/s42977-024-00205-7
8
Magdy El-Salhy, Kazuo Umezawa. Effects of AP-1 and NF-κB inhibitors on colonic endocrine cells in rats with TNBS-induced colitis. Molecular Medicine Reports 2016; 14(2): 1515 doi: 10.3892/mmr.2016.5444
9
Mayra Sofía Vergara Alvira, Laura Marcela Ahumada Ossa, Elpidia Poveda Espinosa. Estrés, depresión, ansiedad y el hábito alimentario en personas con síndrome de intestino irritable. Revista colombiana de Gastroenterología 2022; 37(4): 369 doi: 10.22516/25007440.899
10
Tarek Mazzawi, Magdy El-Salhy. Changes in duodenal enteroendocrine cells in patients with irritable bowel syndrome following dietary guidance. Experimental Biology and Medicine 2017; 242(13): 1355 doi: 10.1177/1535370217699537
11
Tereza Hubkova. No More Pain in the Gut: Lifestyle Medicine Approach to Irritable Bowel Syndrome. American Journal of Lifestyle Medicine 2017; 11(3): 223 doi: 10.1177/1559827617691027
12
Emma Altobelli, Valerio Del Negro, Paolo Angeletti, Giovanni Latella. Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis. Nutrients 2017; 9(9): 940 doi: 10.3390/nu9090940
13
Magdy El-Salhy, Tanisa Patcharatrakul, Jan Gunnar Hatlebakk, Trygve Hausken, Odd Helge Gilja, Sutep Gonlachanvit. Enteroendocrine, Musashi 1 and neurogenin 3 cells in the large intestine of Thai and Norwegian patients with irritable bowel syndrome. Scandinavian Journal of Gastroenterology 2017; 52(12): 1331 doi: 10.1080/00365521.2017.1371793
14
Feng-yun Wang, Min Su, Yong-qiu Zheng, Xiao-ge Wang, Nan Kang, Ting Chen, En-lin Zhu, Zhao-xiang Bian, Xu-dong Tang. Herbal prescription Chang'an II repairs intestinal mucosal barrier in rats with post-inflammation irritable bowel syndrome. Acta Pharmacologica Sinica 2015; 36(6): 708 doi: 10.1038/aps.2014.170
15
TAREK MAZZAWI, DORIS GUNDERSEN, TRYGVE HAUSKEN, MAGDY EL-SALHY. Increased gastric chromogranin A cell density following changes to diets of patients with irritable bowel syndrome. Molecular Medicine Reports 2014; 10(5): 2322 doi: 10.3892/mmr.2014.2498
16
Eugenia Bruzzese, Marcella Pesce, Giovanni Sarnelli, Alfredo Guarino. Pharmacokinetic drug evaluation of rifaximin for treatment of diarrhea-predominant irritable bowel syndrome. Expert Opinion on Drug Metabolism & Toxicology 2018; 14(7): 753 doi: 10.1080/17425255.2018.1488964
17
Sara Rurgo, Viviana Vaino, Marta Andreozzi, Marta Pagliaro, Piera Senneca, Gianmarco Di Giorgio, Eleonora Efficie, Giovanni Sarnelli, Marcella Pesce. Predictors of abdominal pain severity in patients with constipation-prevalent irritable bowel syndrome. Journal of Basic and Clinical Physiology and Pharmacology 2022; 33(5): 665 doi: 10.1515/jbcpp-2022-0081
18
Wang Chen, Gong Binbin, Sun Lidan, Zhou Qiang, Han Jing. Evolution of peptide YY analogs for the management of type 2 diabetes and obesity. Bioorganic Chemistry 2023; 140: 106808 doi: 10.1016/j.bioorg.2023.106808
19
Magdy El-Salhy, Jan Gunnar Hatlebakk, Odd Helge Gilja, Trygve Hausken. Irritable bowel syndrome: recent developments in diagnosis, pathophysiology, and treatment. Expert Review of Gastroenterology & Hepatology 2014; 8(4): 435 doi: 10.1586/17474124.2014.888952
20
Magdy El-Salhy. Nutritional Management of Gastrointestinal Diseases and Disorders. Nutrients 2019; 11(12): 3013 doi: 10.3390/nu11123013
21
Tarek Mazzawi. Gut Microbiota Manipulation in Irritable Bowel Syndrome. Microorganisms 2022; 10(7): 1332 doi: 10.3390/microorganisms10071332
22
Magdy El-Salhy. Recent advances in the diagnosis of irritable bowel syndrome. Expert Review of Gastroenterology & Hepatology 2015; 9(9): 1161 doi: 10.1586/17474124.2015.1067138
23
Magdy El-Salhy. Recent developments in the pathophysiology of irritable bowel syndrome. World Journal of Gastroenterology 2015; 21(25): 7621-7636 doi: 10.3748/wjg.v21.i25.7621
24
Magdy El-Salhy, Trygve Hausken. The role of the neuropeptide Y (NPY) family in the pathophysiology of inflammatory bowel disease (IBD). Neuropeptides 2016; 55: 137 doi: 10.1016/j.npep.2015.09.005
25
T Mazzawi, T Hausken, D Gundersen, M El-Salhy. Effect of dietary management on the gastric endocrine cells in patients with irritable bowel syndrome. European Journal of Clinical Nutrition 2015; 69(4): 519 doi: 10.1038/ejcn.2014.151
26
Tarek Mazzawi, Magdy El-Salhy, Gülen Arslan Lied, Trygve Hausken. The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome. Frontiers in Cellular and Infection Microbiology 2021; 11 doi: 10.3389/fcimb.2021.524851
27
Magdy El-Salhy, Jan Gunnar Hatlebakk, Odd Helge Gilja. Abnormalities in endocrine and immune cells are correlated in dextran-sulfate-sodium-induced colitis in rats. Molecular Medicine Reports 2017; 15(1): 12 doi: 10.3892/mmr.2016.6023
28
Britta Eggenreich, Elke Scholz, David Johannes Wurm, Florian Forster, Oliver Spadiut. The production of a recombinant tandem single chain fragment variable capable of binding prolamins triggering celiac disease. BMC Biotechnology 2018; 18(1) doi: 10.1186/s12896-018-0443-0
29
UEG Week 2016 Poster Presentations. United European Gastroenterology Journal 2016; 4(5_suppl): A157 doi: 10.1177/2050640616663689
30
Hirokazu Fukui, Xin Xu, Hiroto Miwa. Role of Gut Microbiota-Gut Hormone Axis in the Pathophysiology of Functional Gastrointestinal Disorders. Journal of Neurogastroenterology and Motility 2018; 24(3): 367 doi: 10.5056/jnm18071
31
Magdy El-Salhy, Jan Gunnar Hatlebakk, Odd Helge Gilja, Trygve Hausken. Densities of rectal peptide YY and somatostatin cells as biomarkers for the diagnosis of irritable bowel syndrome. Peptides 2015; 67: 12 doi: 10.1016/j.peptides.2015.02.008
32
Magdy El-Salhy, Odd Helge Gilja, Doris Gundersen, Trygve Hausken. Endocrine cells in the oxyntic mucosa of the stomach in patients with irritable bowel syndrome. World Journal of Gastrointestinal Endoscopy 2014; 6(5): 176-185 doi: 10.4253/wjge.v6.i5.176
33
Luo‐Ting Hsu, Kuan‐Yang Hung, Hsiu‐Wei Wu, Wei‐Wen Liu, Meng‐Ping She, Tsung‐Chun Lee, Chin‐Hung Sun, Wei‐Hsuan Yu, Andre G Buret, Linda Chia‐Hui Yu. Gut‐derived cholecystokinin contributes to visceral hypersensitivity via nerve growth factor‐dependent neurite outgrowth. Journal of Gastroenterology and Hepatology 2016; 31(9): 1594 doi: 10.1111/jgh.13296
34
Joanna Oświęcimska, Agnieszka Szymlak, Wojciech Roczniak, Katarzyna Girczys-Połedniok, Jarosław Kwiecień. New insights into the pathogenesis and treatment of irritable bowel syndrome. Advances in Medical Sciences 2017; 62(1): 17 doi: 10.1016/j.advms.2016.11.001
35
Magdy El-Salhy, Tanisa Patcharatrakul, Jan Gunnar Hatlebakk, Trygve Hausken, Odd Helge Gilja, Sutep Gonlachanvit. Chromogranin A cell density in the large intestine of Asian and European patients with irritable bowel syndrome. Scandinavian Journal of Gastroenterology 2017; 52(6-7): 691 doi: 10.1080/00365521.2017.1305123
36
Magdy El-Salhy, Jan Gunnar Hatlebakk, Trygve Hausken. Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones. Nutrients 2019; 11(8): 1824 doi: 10.3390/nu11081824
37
LA Costa, TNF Gomes, CU Braga, L Lenz, SJ Miszputen, O Ambrogini. Irritable bowel syndrome and small intestinal bacterial overgrowth: Assessment with breath test. Archives of Clinical Gastroenterology 2020; : 041 doi: 10.17352/2455-2283.000077
38
Felicitas Engel, Philine Banzhaf, Sabrina Berens. Trauma und Reizdarm. Trauma & Gewalt 2024; 18(4): 340 doi: 10.21706/tg-18-4-340
39
Magdy El-Salhy, Tanisa Patcharatrakul, Sutep Gonlachanvit. The role of diet in the pathophysiology and management of irritable bowel syndrome. Indian Journal of Gastroenterology 2021; 40(2): 111 doi: 10.1007/s12664-020-01144-6
40
Tarek Mazzawi, Gülen Arslan Lied, Dag André Sangnes, Magdy El-Salhy, Johannes R. Hov, Odd Helge Gilja, Jan Gunnar Hatlebakk, Trygve Hausken, John Green. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation. PLOS ONE 2018; 13(11): e0194904 doi: 10.1371/journal.pone.0194904
41
B Sivaprakash. Physiology and Neurobiology of Stress and the Implications for Physical Health . Annals of SBV 2014; 3(1): 25 doi: 10.5005/jp-journals-10085-3105
42
Magdy El-Salhy, Jan Gunnar Hatlebakk, Odd Helge Gilja, Trygve Hausken. The relation between celiac disease, nonceliac gluten sensitivity and irritable bowel syndrome. Nutrition Journal 2015; 14(1) doi: 10.1186/s12937-015-0080-6
43
Juan José Sebastián Domingo, Beatriz Sebastián Sánchez. Psiconeuroinmunología en el síndrome del intestino irritable. Gastroenterología y Hepatología 2015;  doi: 10.1016/j.gastrohep.2015.01.005
44
Magdy El-Salhy, Tarek Mazzawi. Fecal microbiota transplantation for managing irritable bowel syndrome. Expert Review of Gastroenterology & Hepatology 2018; 12(5): 439 doi: 10.1080/17474124.2018.1447380
45
Tarek Mazzawi, Doris Gundersen, Trygve Hausken, Magdy El-Salhy. Increased Chromogranin A Cell Density in the Large Intestine of Patients with Irritable Bowel Syndrome after Receiving Dietary Guidance. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/823897
46
Jingmei Lin, Henry D. Appelman. Practical Gastrointestinal Pathology. 2021; : 145 doi: 10.1007/978-3-030-51268-2_7
47
Aysooda Azimi, Masoud Yavarmanesh, Mehran Gholamin. Comparing lactic acid bacteria biodiversity in irritable bowel syndrome and healthy gut microbiota. Food Science & Nutrition 2024;  doi: 10.1002/fsn3.4477
48
Masoomeh Asadi, Sedigheh Fayazi, Sara Adarvishi, Pejman Alavinejad, Mahmood Latifi, Akbar Soleimani. The Effect of Benson Relaxation on Quality of Life of Patients with Irritable Bowel Syndrome. Jundishapur Journal of Chronic Disease Care 2016; 5(4) doi: 10.17795/jjcdc-31068
49
Magdy El-Salhy, Synne Otterasen Ystad, Tarek Mazzawi, Doris Gundersen. Dietary fiber in irritable bowel syndrome (Review). International Journal of Molecular Medicine 2017; 40(3): 607 doi: 10.3892/ijmm.2017.3072
50
Tarek Mazzawi, Magdy El-Salhy. Effect of diet and individual dietary guidance on gastrointestinal endocrine cells in patients with irritable bowel syndrome (Review). International Journal of Molecular Medicine 2017; 40(4): 943 doi: 10.3892/ijmm.2017.3096
51
Alison Coutts. Nursing management of irritable bowel syndrome. Nursing Standard 2019; 34(5): 76 doi: 10.7748/ns.2019.e11363
52
Chenyu Li, Yujun Shuai, Xiaodong Zhou, Hongxia Chen. Association between Helicobacter pylori infection and irritable bowel syndrome. Medicine 2020; 99(50): e22975 doi: 10.1097/MD.0000000000022975
53
MAGDY EL-SALHY, ODD HELGE GILJA, JAN GUNNAR HATLEBAKK, TRYGVE HAUSKEN. Stomach antral endocrine cells in patients with irritable bowel syndrome. International Journal of Molecular Medicine 2014; 34(4): 967 doi: 10.3892/ijmm.2014.1887
54
Giovanni Barbara, Christine Feinle-Bisset, Uday C. Ghoshal, Javier Santos, Stepen J. Vanner, Nathalie Vergnolle, Erwin G. Zoetendal, Eamonn M. Quigley. The Intestinal Microenvironment and Functional Gastrointestinal Disorders. Gastroenterology 2016; 150(6): 1305 doi: 10.1053/j.gastro.2016.02.028
55
Bo Li, Xiong-Fei Luo, Si-Wen Liu, Na Zhao, Hua-Nan Li, Wei Zhang, Ying-Ying Chen, An Bao, Jin-Gui Wang, Qiang-Song Wang, Morry Silberstein. Abdominal Massage Reduces Visceral Hypersensitivity via Regulating GDNF and PI3K/AKT Signal Pathway in a Rat Model of Irritable Bowel Syndrome. Evidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/3912931
56
Gabrio Bassotti. Targeting diarrhea-predominant irritable bowel syndrome: hopes or hypes?. Expert Opinion on Investigational Drugs 2024; : 1 doi: 10.1080/13543784.2024.2347296
57
Magdy El-Salhy, Tanisa Patcharatrakul, Sutep Gonlachanvit. Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21<sup>st</sup> century. World Journal of Gastroenterology 2021; 27(22): 2921-2943 doi: 10.3748/wjg.v27.i22.2921
58
Xiangxue Ma, Xiaoge Wang, Nan Kang, Ting Chen, Haijie Ji, Lin Lv, Xiaolan Yin, Yaxin Tian, Rui Zheng, Yuanzhi Duan, Fengyun Wang, Xudong Tang, Jiande D. Z. Chen. The Effect of Tong‐Xie‐Yao‐Fang on Intestinal Mucosal Mast Cells in Postinfectious Irritable Bowel Syndrome Rats. Evidence-Based Complementary and Alternative Medicine 2017; 2017(1) doi: 10.1155/2017/9086034
59
Magdy El-Salhy, Jan Gunnar Hatlebakk. Changes in enteroendocrine and immune cells following colitis induction by TNBS in rats. Molecular Medicine Reports 2016; 14(6): 4967 doi: 10.3892/mmr.2016.5902
60
Magdy El-Salhy, Jan Gunnar Hatlebakk, Trygve Hausken. Possible role of peptide YY (PYY) in the pathophysiology of irritable bowel syndrome (IBS). Neuropeptides 2020; 79: 101973 doi: 10.1016/j.npep.2019.101973
61
S. Pellissier, B. Bonaz. Anxiety. Vitamins and Hormones 2017; 103: 327 doi: 10.1016/bs.vh.2016.09.005
62
Emanuele Sinagra, Francesca Rossi, Dario Raimondo, Giuseppe Conoscenti, Andrea Anderloni, Valentina Guarnotta, Marcello Maida. Tenapanor for the treatment of irritable bowel syndrome with constipation. Expert Review of Clinical Pharmacology 2020; 13(5): 473 doi: 10.1080/17512433.2020.1762570
63
Magdy El-Salhy, Tefera Solomon, Trygve Hausken, Odd Helge Gilja, Jan Gunnar Hatlebakk. Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease. World Journal of Gastroenterology 2017; 23(28): 5068-5085 doi: 10.3748/wjg.v23.i28.5068
64
Magdy El-Salhy, Trygve Hausken, Odd Helge Gilja, Jan Gunnar Hatlebakk. The possible role of gastrointestinal endocrine cells in the pathophysiology of irritable bowel syndrome. Expert Review of Gastroenterology & Hepatology 2017; 11(2): 139 doi: 10.1080/17474124.2017.1269601
65
Vlad Alexandru Ionescu, Gina Gheorghe, Teodor Florin Georgescu, Nicolae Bacalbasa, Florentina Gheorghe, Camelia Cristina Diaconu. The Latest Data Concerning the Etiology and Pathogenesis of Irritable Bowel Syndrome. Journal of Clinical Medicine 2024; 13(17): 5124 doi: 10.3390/jcm13175124
66
Magdy El-Salhy, Odd Helge Gilja, Doris Gundersen, Jan Gunnar Hatlebakk, Trygve Hausken. Duodenal Chromogranin A Cell Density as a Biomarker for the Diagnosis of Irritable Bowel Syndrome. Gastroenterology Research and Practice 2014; 2014: 1 doi: 10.1155/2014/462856
67
TAREK MAZZAWI, MAGDY EL-SALHY. Changes in small intestinal chromogranin A-immunoreactive cell densities in patients with irritable bowel syndrome after receiving dietary guidance. International Journal of Molecular Medicine 2016; 37(5): 1247 doi: 10.3892/ijmm.2016.2523
68
R. Carmona-Sánchez, M.E. Icaza-Chávez, M.V. Bielsa-Fernández, O. Gómez-Escudero, F. Bosques-Padilla, E. Coss-Adame, F. Esquivel-Ayanegui, Á.R. Flores-Rendón, M.A. González-Martínez, F. Huerta-Iga, A. López-Colombo, T.H. Méndez-Gutiérrez, A. Noble-Lugo, J.R. Nogueira-de Rojas, R.H. Raña-Garibay, J.M. Remes-Troche, F. Roesch-Dietlen, M.J. Schmulson, J.C. Soto-Pérez, J.L. Tamayo, L.F. Uscanga, M.Á. Valdovinos, J. Valerio-Ureña, M.R. Zavala-Solares. The Mexican consensus on irritable bowel syndrome. Revista de Gastroenterología de México (English Edition) 2016; 81(3): 149 doi: 10.1016/j.rgmxen.2016.01.004
69
Tarek Mazzawi, Trygve Hausken, Magdy El-Salhy. Changes in colonic enteroendocrine cells of patients with irritable bowel syndrome following fecal microbiota transplantation. Scandinavian Journal of Gastroenterology 2022; 57(7): 792 doi: 10.1080/00365521.2022.2036809
70
Magdy El‑Salhy, Odd Gilja, Jan Hatlebakk. Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting. Molecular Medicine Reports 2019;  doi: 10.3892/mmr.2019.10284
71
T Mazzawi, T Hausken, D Gundersen, M El-Salhy. Dietary guidance normalizes large intestinal endocrine cell densities in patients with irritable bowel syndrome. European Journal of Clinical Nutrition 2016; 70(2): 175 doi: 10.1038/ejcn.2015.191
72
Yoshiharu Uno. Hypothesis: Mechanism of irritable bowel syndrome in inflammatory bowel disease. Medical Hypotheses 2019; 132: 109324 doi: 10.1016/j.mehy.2019.109324
73
Sameh Mahmoud Abdel Monem, Elsaid Galal Elbadrawy, Sally Mahmoud Shalaby, Doaa Mahmoud Hendawy, Sherif Mahmoud Hassan, Nagla Abd Almonem. The role of serum gastric peptide ghrelin hormone level in irritable bowel syndrome at Zagazig University Hospitals. Journal of Medicine and Life 2022; 15(12): 1525 doi: 10.25122/jml-2022-0089
74
V. M. Makhov, A. A. Balakhonov, M. A. Isaikina, Yu. A. Doronina. Inflammatory factor in the clinical picture and therapy of irritable bowel syndrome. Medical Council 2018; (14): 67 doi: 10.21518/2079-701X-2018-14-67-72
75
Tarek Mazzawi, Øystein Eikrem, Gülen Arslan Lied, Trygve Hausken. Abnormal Uroguanylin Immunoreactive Cells Density in the Duodenum of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Changes following Fecal Microbiota Transplantation. Gastroenterology Research and Practice 2020; 2020: 1 doi: 10.1155/2020/3520686
76
Karolina Niewinna, Anna Zielińska, Jakub Fichna. Recent advances in the pharmacological management of constipation predominant irritable bowel syndrome. Expert Opinion on Pharmacotherapy 2020; 21(1): 73 doi: 10.1080/14656566.2019.1688784
77
Emanuele Sinagra, Gaetano Cristian Morreale, Ghazaleh Mohammadian, Giorgio Fusco, Valentina Guarnotta, Giovanni Tomasello, Francesco Cappello, Francesca Rossi, Georgios Amvrosiadis, Dario Raimondo. New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond. World Journal of Gastroenterology 2017; 23(36): 6593-6627 doi: 10.3748/wjg.v23.i36.6593
78
Magdy El-Salhy, Doris Gundersen. Diet in irritable bowel syndrome. Nutrition Journal 2015; 14(1) doi: 10.1186/s12937-015-0022-3
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345